Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Lloyd Everson, Marc Kerlin, Philip Watts, Chet Dye, Richard Klausner, and More

Premium

In gearing up for the launch of its CLIA-certified next-generation sequencing based lab and diagnostics platform for personalizing cancer treatments, MolecularHealth has appointed a management team to run its newly opened US offices in Woodlands, Texas.

The management team will be headed by Lloyd Everson, who will be CEO of the US division of MolecularHealth. Marc Kerlin will be COO, Philip Watts will be general counsel, and Chet Dye will be chief development officer.

Everson joins MolecularHealth from US Oncology, where he was vice chairman and a member of its board of directors. Kerlin was most recently president and CEO and e+Cancer Care. Watts helped advance the business plan at US Physiatry and was employed at US Oncology for several years in various capacities, including general counsel. Dye was chief development officer at Solis Women's Health and also formerly national VP at US Oncology.


Illumina has appointed Richard Klausner as senior VP and chief medical officer. Klausner joins Illumina from The Column Group venture capital firm where he was managing partner. He was also previously the executive director for global health at the Bill and Melinda Gates Foundation and director of the National Cancer Institute from 1995 to 2001.

At Illumina, Klausner will report to CEO Jay Flatley and spearhead efforts to integrate genomics strategies in to mainstream medical practice.


Prometheus Laboratories appointed as its new CEO Lisa Miller, previously corporate VP at Agilent subsidiary Dako. Miller will take over for Cathy Kerzner, who has been serving as interim CEO of Prometheus.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.